<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">143</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0172</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A novel mutation in <italic>CRYAB</italic> associated with autosomal dominant congenital nuclear cataract in a Chinese family</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Qiang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Junjie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Ming</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mothobi</surname><given-names>Maneo Emily</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yuanyuan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zheng</surname><given-names>Fang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Center for Gene Diagnosis, Zhongnan Hospital, Wuhan University, Wuhan, China</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, Zhongnan Hospital, Wuhan University, Wuhan, China</aff><aff id="aff3"><label>3</label>Health Research and Laboratory Services, Maseru, Lesotho</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Professor Dr. Fang Zheng, Center for Gene Diagnosis, Zhongnan Hospital, Donghu road 169#, Wuhan, 430071, China; Phone: 86&#x02013;27&#x02013;61155235; FAX: 86&#x02013;27&#x02013;67813233; email: <email xlink:href="zhengfang@whu.edu.cn">zhengfang@whu.edu.cn</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>10</day><month>7</month><year>2009</year></pub-date><volume>15</volume><fpage>1359</fpage><lpage>1365</lpage><history><date date-type="received"><day>07</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>07</day><month>7</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>To identify the genetic defects associated with autosomal dominant congenital nuclear cataract in a Chinese family.</p></sec><sec><title>Methods</title><p>Clinical data were collected, and the phenotypes of the affected members in this family were recorded by slit-lamp photography. Genomic DNA was isolated from peripheral blood. Mutations were screened in cataract-associated candidate genes through polymerase chain reaction (PCR) analyses and sequencing. Structural models of the wild-type and mutant &#x003b1;B-crystallin were generated and analyzed by SWISS-MODEL.</p></sec><sec><title>Results</title><p>Mutation screening identified only one heterozygous G&#x02192;A transition at nucleotide 32 in the first exon of &#x003b1;B-crystallin (<italic>CRYAB</italic>), resulting in an amino acid change from arginine to histidine at codon 11 (R11H). This mutation segregated in all available affected family members but was not observed in any of the unaffected persons of the family. The putative mutation disrupted a restriction site for the enzyme, Fnu4HI, in the affected family members. The disruption, however, was not found in any of the randomly selected ophthalmologically normal individuals or in 40 unrelated senile cataract patients. Computer-assisted prediction suggested that this mutation affected the biochemical properties as well as the structure of &#x003b1;B-crystallin.</p></sec><sec><title>Conclusions</title><p>These results supported the idea that the novel R11H mutation was responsible for the autosomal dominant nuclear congenital cataract in this pedigree.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Zheng</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Hereditary congenital cataract (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604307">604307</ext-link>) is an opacification of the ocular lens, which frequently results in visual impairment or even blindness during infancy or early childhood and accounts for one-tenth of the cases of childhood blindness [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r2">2</xref>]. Despite the great advances in the clinical management of cataracts as well as a better understanding of lens structure and function, the relationships among cataract etiology, morphology, and underlying mechanisms remain unclear. Accumulating evidence indicate that the genetic background plays an important role in the whole process. Currently, most progress has been made in identifying the genes causing autosomal dominant congenital cataract. About 39 genetic loci for congenital cataract have also been mapped, although this number is constantly increasing. Of those families with inherited cataracts for whom the mutant gene is known, about half show mutations in crystallin genes (&#x003b1;A-crystallin [<italic>CRYAA</italic>]; &#x003b1;B-crystallin [<italic>CRYAB</italic>]; &#x003b2;A1/A3-crystallin [<italic>CRYBA1/A3</italic>]; &#x003b2;B1-crystallin [<italic>CRYBB1</italic>]; &#x003b2;B2-crystallin [<italic>CRYBB2</italic>]; &#x003b2;B3-crystallin [<italic>CRYBB3</italic>]; &#x003b3;C-crystallin [<italic>CRYGC</italic>]; &#x003b3;D-crystallin [<italic>CRYGD</italic>]; &#x003b3;S-crystallin [<italic>CRYGS</italic>]), about a quarter in connexin genes (gap junction protein alpha 8 [<italic>GJA8</italic>]; gap junction protein alpha 3 [<italic>GJA3</italic>]), and the remainder in genes for heat shock transcription factor-4 (<italic>HSF4</italic>), major intrinsic protein (<italic>MIP</italic>), and beaded filament structural protein-2 (<italic>BFSP2</italic>) [<xref ref-type="bibr" rid="r3">3</xref>-<xref ref-type="bibr" rid="r7">7</xref>].</p><p>&#x003b1;-Crystallins are the most abundant soluble proteins in the lens and play essential roles in maintaining lens transparency. They are mainly composed of two related proteins, &#x003b1;A- and &#x003b1;B-crystallins, in a molar ratio of roughly 3:1. These subunits are encoded by individual genes, <italic>CRYAA</italic> and <italic>CRYAB</italic>, localized on different chromosomes and members of the small heat-shock protein family (sHSP) [<xref ref-type="bibr" rid="r8">8</xref>]. In the vertebrate lens, &#x003b1;A-and &#x003b1;B-crystallins form hetero-oligomers of variable size and a quaternary structure that binds and sequesters damaged proteins, preventing the formation of particulates that scatter light [<xref ref-type="bibr" rid="r9">9</xref>]. In contrast to &#x003b1;A-crystallin, &#x003b1;B-crystallin can also be found in tissues other than the lens and is strongly expressed in the heart, muscle, brain, and kidney. Mutations in <italic>CRYAB</italic> are associated with a broad variety of neurologic, cardiac, and muscular disorders, suggesting that it has a general cellular function [<xref ref-type="bibr" rid="r10">10</xref>-<xref ref-type="bibr" rid="r12">12</xref>].</p><p>In the present study, we investigated a four-generation Chinese family with autosomal dominant congenital nuclear cataract and identified a novel missense mutation in exon 1 of <italic>CRYAB</italic> that leads to an exchange of arginine for histidine at codon 11 (R11H).</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Family enrollment and clinical data</title><p>A four-generation family (<xref ref-type="fig" rid="f1">Figure 1</xref>) was recruited into Zhongnan Hospital (Wuhan, China). The research was approved by Zhongnan Hospital Research Ethics Committee and followed the tenets of the Declaration of Helsinki. Written informed consents were obtained from all the participating adult individuals and the parents of children under 16 years old. The participating subjects underwent clinical ocular examination by a senior ophthalmologist to assess the cataract phenotype through either slit-lamp photography or direct ophthalmoscope. Two hundred subjects without diagnostic features of congenital cataract and 40 subjects diagnosed with senile cataract were recruited from the Chinese Han population in Zhongnan Hospital to serve as normal controls.</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>The Chinese autosomal dominant congenital cataract pedigree. Square symbols denote males, and the circle symbols denote females. The shaded symbols indicate ophthalmologist-confirmed congenital cataract. The arrow points to the proband. The transmission pattern suggested the cataract was inherited in an autosomal dominant manner. Individuals who participated in this study are indicated by an asterisk and screened for mutations.</p></caption><graphic xlink:href="mv-v15-1359-f1"/></fig></sec><sec><title>PCR based sequencing</title><p>Mutation screening was performed through candidate gene approach. Known candidate genes for hereditary cataracts such as <italic>CRYAA</italic>, <italic>CRYAB</italic>, <italic>CRYBA1</italic>/<italic>A3</italic>, <italic>CRYBB2</italic>, <italic>CRYGC</italic>, <italic>CRYGD</italic>, <italic>GJA8</italic>, <italic>GJA3</italic>, <italic>MIP</italic>, and <italic>BFSP2</italic> were analyzed by polymerase chain reaction (PCR) amplification followed by direct DNA sequencing. The sets of primer pairs used are listed in <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Primers used for mutation screening.</title></caption><table frame="hsides" rules="groups"><col width="90" span="1"/><col width="280" span="1"/><col width="70" span="1"/><col width="74" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Gene symbol and amplified fragments</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Primer sequences</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>PCR product size (bp)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Annealing temperature (&#x000b0;C)</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>CRYAA</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-CTCCAGGTCCCCGTGGTA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">251<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">65<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-AGGAGAGGCCAGCACCAC-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-CTGTCTCTGCCAACCCCAG-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">220<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">65<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-CTGTCCCACCTCTCAGTGCC-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-GGCAGCTTCTCTGGCATG-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">309<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">65<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-GAGCCAGCCGAGGCAATG-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>CRYAB</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-TGCATATATAAGGGGCTGGCTGTA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">363<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">65<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:3&#x02032;-CAGGGTAGGAAAGGAAAATGGATG-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-AGGATGAATTACCCGGACAGAAAG-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">220<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-ACCCCTGATCCCGACTGTTAT-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-TGAGTTCTGGGCAGGTGATAATAGTT-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">273<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-AGCTTGATAATTTGGGCCTGCC-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>CRYBA1/A3</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-CAATCCTCCCTCCACCTC-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">520<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:3&#x02032;-TCCTTCCTTCTAGCTTTGG-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>CRYBB2</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-CCCCTCGTTCACCCTCCCATCA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">506<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">69<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-CACTGTGTCCAAGGTCACACAGCTAAGC-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>CRYGC</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exons 1,2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-TCAATCATATAGACAGAGCCA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">784<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-ATCTCCATCTAACCTTAGGT-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-AATGACAATTCCATGCCACA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">534<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-CCCACCCCATTCACTTCTTA-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>CRYGD</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exons 1,2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-TGATAGCAATCCGAATACTCCA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">776<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-GGGTAATACTTTGCTTATGTGGGGAG-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-GTCCTCACCAAGCTGGACTG-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">496<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-CCATTTGCCTCGTGTGTGTA-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>GJA8</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-AGGAGGTGAATGAGCACTCCA-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">251<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-GTGCCCCACGTACATCAGG-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>MIP</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-GAGGAGGTAACACTGTGGCAGC-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">198<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:3&#x02032;-AGAAGCCAACGGCCAGG-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>BFSP2</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-GCTGCTGCACAAACAGTTGG-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">286<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-TTCTGTTTCTAATGAGGTTGAACTTGTTA-3&#x02032;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>GJA3</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F:5&#x02032;-TGCAACACCCAGCAGCC-3&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">474<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="left" rowspan="1" colspan="1">R:5&#x02032;-GGCCACCGCCAGCAT-3&#x02032;</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>Exons of known candidate genes for hereditary cataracts were amplified from genomic DNA by PCR amplification in a 25 &#x003bc;l reaction volume with 10 pmol forward primers and reverse primers. F: forward primer; R: reverse primer.</p></table-wrap-foot></table-wrap><p>The sequencing results were analyzed using <ext-link ext-link-type="uri" xlink:href="http://www.technelysium.com.au/chromas.html">Chromas</ext-link> (version 2.3) and compared with the reference sequence in the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">NCBI</ext-link> database. Any interesting sequence variation was later confirmed in the rest of the available family members and representative controls by restriction fragment length polymorphism (RFLP).</p></sec><sec><title>PCR-RFLP analysis</title><p>RFLP analysis was used to determine whether the mutation cosegregated with the disease in the family and whether the mutation was absent in 200 randomly chosen ophthalmologically normal individuals and 40 senile cataract patients. In brief, a partial segment of <italic>CRYAB</italic>, which contained the putative mutation, was amplified using primers 5&#x02032;-TGC ATA TAT AAG GGG CTG GCT GTA-3&#x02032; (forward primer) and 5&#x02032;-CAG GGT AGG AAA GGA AAA TGG ATG-3&#x02032; (reverse primer). The PCR product was then restriction digested with Fnu4HI (MBI Fermentas, Vilnius, Lithuania) at 37&#x000a0;&#x000b0;C overnight, and the resulting fragments were separated on 8% polyacrylamide gel. The common G allele of the wild-type <italic>CRYAB</italic> yielded the fragments of 221 bp, 81 bp, and 30 bp while the presence of the rare A allele in the mutant form generated fragments of 221 bp, 110 bp, and 30 bp. The schema for the mutation screening by PCR-RFLP method is shown in <xref ref-type="fig" rid="f2">Figure 2A</xref>.</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Confirmation of the mutation by PCR-RFLP method. The positions of the Fnu4HI restriction sites (GC/NGC) in the target sequence are represented (<bold>A</bold>). The schematic overviews show that one Fnu4HI restriction site was disrupted in the mutant form as a result of the mutation. In the wild-type form, there are two major fragments of 221 bp and 81 bp. In the disease form, one of the Fnu4HI restriction sites is disrupted, resulting in a longer fragment of 110 bp (boxed region). This longer fragment can only be observed in the affected family members (<bold>B</bold>). M, DNA Marker; Lane 1, unrelated normal control; Lane 2, senile cataract patient; Lane 3, unaffected member of the family; Lane 4 and 5, proband and his son; Lane 6, undigested PCR product.</p></caption><graphic xlink:href="mv-v15-1359-f2"/></fig></sec><sec><title>Molecular modeling</title><p>Biophysical predictions of the altered protein were analyzed using Bioinformatics tools. In particular, we used <ext-link ext-link-type="uri" xlink:href="http://antheprot-pbil.ibcp.fr/">Antheprot 2000</ext-link> (version 6.0; IBCP, Lyon, France) for secondary structures and <ext-link ext-link-type="uri" xlink:href="http://www.expasy.org/tools/protscale.html">ProtScale</ext-link> (provided by the Swiss Institute of Bioinformatics, Geneva, Switzerland) for hydrophilicity. Three-dimensional structures were modeled employing the <ext-link ext-link-type="uri" xlink:href="http://swissmodel.expasy.org/">Swiss Model</ext-link> server program (provided in collaboration by the Biozentrum; University Basel, Switzerland), the Swiss Institute of Bioinformatics (Geneva, Switzerland) and the Advanced Biomedical Computing Center (NCI Frederick, MD) [<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r14">14</xref>] . The resulting protein database files were visualized using <ext-link ext-link-type="uri" xlink:href="http://spdbv.vital-it.ch/">Swiss-Pdb Viewer</ext-link> (version 4.01, provided by Swiss Institute of Bioinformatics, Geneva, Switzerland) and <ext-link ext-link-type="uri" xlink:href="http://www.umass.edu/microbio/rasmol/">Rasmol</ext-link> (version 2.7.4.2, developed by the National Science Foundation, Arlington VA). Furthermore, the resulting protein database files were calculated using <ext-link ext-link-type="uri" xlink:href="http://www.umass.edu/microbio/rasmol/">Rasmol</ext-link> (version 2.7.4.2).</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Clinical findings</title><p>We identified a four-generation Chinese family with 23 living members, among whom there were nine individuals affected with cataract (<xref ref-type="fig" rid="f1">Figure 1</xref>). According to the history and medical records, all affected members had clinically suspected cataract before the age of five. Morphologically, all available affected individuals displayed bilateral nuclear cataracts of variable severity with no other ocular or systemic abnormalities (<xref ref-type="fig" rid="f3">Figure 3</xref>). The pedigree of the family suggests an autosomal dominant mode of inheritance.</p><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>Slit-lamp photographs of the eye of the proband. Slit lamp photographs of the eye of the proband (III:3). <bold>A</bold>: Front view of the eye of the proband, showing cataract phenotype. <bold>B</bold>: Slit lamp view of the len of the proband. Lens opacities were mainly located in the nuclear area of lenses as well as in the embryonal and fetal areas.</p></caption><graphic xlink:href="mv-v15-1359-f3"/></fig></sec><sec><title>Mutation analysis</title><p>To identify the mutation that caused cataract in this pedigree, we screened 16 mutation hot spots of 10 genes (<xref ref-type="table" rid="t1">Table 1</xref>) in all recruited family members by PCR-based DNA sequencing. Sequencing analysis revealed a heterozygous G&#x02192;A transition at nucleotide 32 in <italic>CRYAB</italic>. At the protein level, it leads to an amino acid change in the first exon from arginine to histidine at codon 11 (R11H; <xref ref-type="fig" rid="f4">Figure 4</xref>).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>Mutation analysis of <italic>CRYAB</italic>. Sequence chromatograms of the partial fragment (363 bp) of <italic>CRYAB</italic> in one unaffected individual of the autosomal dominant congenital cataract (ADCC) family demonstrated a nucleotide sequence encoding Arg (R) at codon 11. Sequence chromatograms of one affected individual demonstrate a G to A transition resulting in an amino acid substitution of Arg by His.</p></caption><graphic xlink:href="mv-v15-1359-f4"/></fig></sec><sec><title>PCR-RFLP analysis</title><p>To confirm the mutation, PCR-RFLP analysis was performed. The results showed that affected individuals carried both the wild-type allele and the mutant allele, indicating a heterozygous mutation whereas unaffected individuals in the family, unrelated normal controls, and senile cataract patients showed only the wild-type allele (<xref ref-type="fig" rid="f2">Figure 2B</xref>).</p></sec><sec><title>Structure predictions</title><p>Computer-assisted prediction of human &#x003b1;B-crystallin was performed to better understand the effects of the mutation on its biochemical properties and structure. Using the proteomics program of the <ext-link ext-link-type="uri" xlink:href="http://www.expasy.org/">Expasy Proteomics</ext-link> server, we compared several features between the wild-type and the mutant protein. Results by software <ext-link ext-link-type="uri" xlink:href="http://antheprot-pbil.ibcp.fr/">Antheprot 2000</ext-link> (version 6.0) showed that the R11H mutation caused variation of secondary structure at codon 11 (<xref ref-type="fig" rid="f5">Figure 5</xref>). Moreover, the program <ext-link ext-link-type="uri" xlink:href="http://www.expasy.org/tools/protscale.html">ProtScale</ext-link> predicted that the hydrophilicity of the corresponding region (<xref ref-type="fig" rid="f6">Figure 6</xref>) was changed as well as the isoelectric point (pI) of the entire protein (from pH 6.7 in the wild-type &#x003b1;B-crystallin to pH 6.5 in the mutated form). Even more striking was the alteration of the electrostatic potential (from a positive potential in wild-type to a negative potential in mutant form; <xref ref-type="fig" rid="f7">Figure 7A,B</xref>) and the tertiary structure (<xref ref-type="table" rid="t2">Table 2</xref> and <xref ref-type="fig" rid="f7">Figure 7C,D</xref>).</p><fig id="f5" fig-type="figure" position="float"><label>Figure 5</label><caption><p>The predicted secondary structures of the wild-type and the mutant &#x003b1;B-crystallin. The predicted secondary structures of the wild-type form (<bold>A</bold>) and the mutant form (<bold>B</bold>) are shown. The target sequences are labeled with white circles. White: helix, Yellow: sheet, Pale blue: coil.</p></caption><graphic xlink:href="mv-v15-1359-f5"/></fig><fig id="f6" fig-type="figure" position="float"><label>Figure 6</label><caption><p>Hydropathy plot of wild-type and mutated &#x003b1;B-crystallin. The x-axis represents the position of amino acids. The y-axis represents the hydropathy value in a default window size of 7. It was obvious that the mutant form showed lower hydrophilicity in the corresponding region compared with the wild-type form (indicated by white arrows).</p></caption><graphic xlink:href="mv-v15-1359-f6"/></fig><fig id="f7" fig-type="figure" position="float"><label>Figure 7</label><caption><p>Three-dimensional protein structure. The electrostatic potentials are shown in red (negative potential) and green (positive potential) clouds. The alteration from a positive in the wild-type (<bold>A</bold>) to a negative potential in the mutant form (<bold>B</bold>) is indicated by the white arrows. Protein models of wild-type &#x003b1;B-crystallin (<bold>C</bold>) and its mutant form (<bold>D</bold>) are displayed. The antiparallel &#x003b2; sheets are yellow and the &#x003b1; helices are red. The blue sections are the looping regions.</p></caption><graphic xlink:href="mv-v15-1359-f7"/></fig><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Structural characteristics of wild-type &#x003b1;B-crystallin and the R11H mutant form.</title></caption><table frame="hsides" rules="groups"><col width="93" span="1"/><col width="93" span="1"/><col width="92" span="1"/><col width="92" span="1"/><col width="91" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>&#x003b1;B-Crystallin species</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>H-Bonds</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Helices</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Strands</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Turns</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Wild-type<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">76<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">18<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Mutant</td><td valign="top" align="center" rowspan="1" colspan="1">69</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">15</td></tr></tbody></table><table-wrap-foot><p>The protein database files, modeling results in <ext-link ext-link-type="uri" xlink:href="http://swissmodel.expasy.org/">Swiss Model</ext-link> server, were calculated by <ext-link ext-link-type="uri" xlink:href="http://www.umass.edu/microbio/rasmol/">Rasmol</ext-link> (version 2.7.4.2).</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In the present study, we described a novel R11H mutation in <italic>CRYAB</italic>, which was associated with cataractogenesis in a Chinese family. Because some members of the family failed to participate in the study, linkage analysis could not be attempted. Since this mutation segregated perfectly within this family and could not be found in representative controls, we excluded the possibility of a rare polymorphism and considered this new allele as a probable causative molecular lesion.</p><p>Lens crystallins account for nearly 90% of the total lens proteins and play essential roles in maintaining lens transparency. Therefore, mutations in the crystallin genes are strong candidates for congenital cataracts. &#x003b1;B-crystallin belongs to the family of small heat-shock proteins. Their characteristic features are their small size (12&#x02013;43&#x000a0;kDa) and an &#x003b1;-crystallin core domain flanked by an NH<sub>2</sub>-terminal domain and a COOH-terminal domain [<xref ref-type="bibr" rid="r8">8</xref>]. The human &#x003b1;B-crystallin gene consists of three exons. The NH<sub>2</sub>-terminal domain is encoded by the first exon and the &#x003b1;-crystallin/heat-shock protein domain is encoded by exons 2 and 3. To our knowledge, nine mutations in <italic>CRYAB</italic> have been reported in the literature (listed in <xref ref-type="table" rid="t3">Table 3</xref>). Eight out of nine mutations identified in human <italic>CRYAB</italic> affect exon 3. Only a few of the eight mutations are associated with only dominant cataracts, and some are also suggested to be causative for desmin-related myopathy or dilated cardiomyopathy [<xref ref-type="bibr" rid="r15">15</xref>-<xref ref-type="bibr" rid="r22">22</xref>]. Based on the structure of human &#x003b1;B-crystallin, the R11H mutation detected in our present study lies in the NH<sub>2</sub>-terminal domain of &#x003b1;B-crystallin and resulted in dominant cataract phenotype only, which is like the P20S mutation reported previously [<xref ref-type="bibr" rid="r15">15</xref>]. The relationship between <italic>CRYAB</italic> mutations and the clinical phenotype is still unclear.</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Mutations in human <italic>CRYAB</italic>.</title></caption><table frame="hsides" rules="groups"><col width="68" span="1"/><col width="63" span="1"/><col width="72" span="1"/><col width="72" span="1"/><col width="180" span="1"/><col width="64" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Nucleotide position</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Base-pair exchange</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Amino acid position</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Amino acid exchange</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Associated pathologies</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Reference</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">32<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G&#x02192;A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Arg&#x02192;His<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Dominant nuclear cataract<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Present study<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">58<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C&#x02192;T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Pro&#x02192;Ser<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Dominant posterior polar cataract<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r15">15</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">358<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A&#x02192;G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">120<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Arg&#x02192;Gly<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Desmin-related myopathy and cataract<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r16">16</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">418<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G&#x02192;A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">140<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Asp&#x02192;Asn<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Dominant lamellar cataract<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r17">17</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">450<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">delA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">150<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Frameshift<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Dominant posterior polar cataract<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r18">18</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">451<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C&#x02192;T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">151<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Arg&#x02192;stop<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Desmin-related myopathy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r19">19</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">460<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G&#x02192;A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">154<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Gly&#x02192;Ser<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Dilated cardiomyopathy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r20">20</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">464<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">delCT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">155<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Frameshift<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Desmin-related myopathy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r19">19</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">470<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G&#x02192;A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">157<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Arg&#x02192;His<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Dilated cardiomyopathy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r21">21</xref>]<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">514</td><td valign="top" align="center" rowspan="1" colspan="1">G&#x02192;A</td><td valign="top" align="center" rowspan="1" colspan="1">171</td><td valign="top" align="center" rowspan="1" colspan="1">Ala&#x02192;Thr</td><td valign="top" align="center" rowspan="1" colspan="1">Dominant lamellar cataract</td><td valign="top" align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="r22">22</xref>]</td></tr></tbody></table><table-wrap-foot><p>&#x003b1;B-Crystallin gene mutations identified in the present study and other previous studies which were associated with congenital cataract and/or myopathy.</p></table-wrap-foot></table-wrap><p>It was interesting that &#x003b1;B-crystallin was also widely expressed in several non-ocular tissues including in the cardiac and skeletal muscle, and &#x003b1;B-crystallin was shown to be associated with neurologic disorders such as Alzheimer disease, Alexander disease, and amyotrophic lateral sclerosis (ALS); to participate in signaling pathways; and to protect against apoptosis [<xref ref-type="bibr" rid="r23">23</xref>-<xref ref-type="bibr" rid="r26">26</xref>]. The first <italic>CRYAB</italic> mutation was reported by Vicart et al. [<xref ref-type="bibr" rid="r16">16</xref>] who showed that desmin-related myopathy and cataract are caused by a missense mutation R120G in &#x003b1;B-crystallin. Animal models were generated to resolve some of the in vivo functions of &#x003b1;-crystallin. Brady et al [<xref ref-type="bibr" rid="r27">27</xref>,<xref ref-type="bibr" rid="r28">28</xref>]. demonstrated that targeted disruption of mouse <italic>CRYAB</italic> resulted in lenses similar in size to age-matched wild-type lenses with no cataracts reported. Thus, the exact in vivo molecular mechanisms by which &#x003b1;B-crystallin maintain lens transparency remain to be determined. More comprehensive studies will be needed to better understand the mechanism of cataract formation and the true function of &#x003b1;B-crystallin within the cell.</p><p>In this study, the mutant &#x003b1;B-crystallin predicted by the <ext-link ext-link-type="uri" xlink:href="http://antheprot-pbil.ibcp.fr/">Antheprot 2000</ext-link> software and <ext-link ext-link-type="uri" xlink:href="http://swissmodel.expasy.org/">Swiss Model</ext-link> server program showed that the R11H change not only had a significant effect on its secondary and tertiary structures but also on the hydrophilicity, isoelectric point, and electrostatic potential of the protein. As shown in <xref ref-type="table" rid="t2">Table 2</xref>, a striking consequence is the mutant form appears to have less intermolecular hydrogen-bonds, which would reduce the solubility of mutant &#x003b1;B-crystallin and cause cataract. The role of the NH<sub>2</sub>-terminal region of &#x003b1;B-crystallin was reported to control the species-specific assembly of subunits into higher level structures and protein interactions [<xref ref-type="bibr" rid="r29">29</xref>]. This is in keeping with the observation by Liu et al. [<xref ref-type="bibr" rid="r30">30</xref>] that the P20S mutation at the NH<sub>2</sub>-terminus resulted in much attenuated subunit exchange rate and chaperone activity. In addition, it was demonstrated using site-directed mutagenesis that the second residue (Asp) at the NH<sub>2</sub>-terminus of recombinant human &#x003b1;B-crystallin influenced its chaperone-like activity and hydrophobic interactions [<xref ref-type="bibr" rid="r31">31</xref>]. In regard to the R11H mutation in our study, we speculate based on the computer-assisted predictions that the possible mechanisms are as follows. The first possible mechanism is the substitution of Arg by His decreasing the thermodynamic stability of the NH<sub>2</sub>-terminal domain in a subtle way so that the protein is more prone to denaturation. Another possible mechanism is the improper folding of &#x003b1;B-crystallin affecting its interactions with neighboring proteins and destabilizing the complex formation critical for lens transparency. A third possible mechanism is the mutation lowering the solubility of the protein in the cytosol of the lens fiber cells and causing protein aggregation and precipitation, which would lead to cataract formation. Nevertheless, further functional experiments are necessary to explore the underlying mechanisms in details.</p><p>In summary, the present study has identified a novel missense R11H mutation in <italic>CRYAB</italic> that is associated with autosomal dominant congenital nuclear cataract in a four-generation Chinese family. The study further substantiates the genetic and clinical heterogeneity of congenital cataract.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the family members for their kind cooperation. This work was in part supported by the New Century Training Programme Foundation for the Talents by the State (NCET-05&#x02013;0621, China), the Science Fund for Creative Research Groups of NSFC, and the Ministry of Education (No. 20621502 and IRT0543).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resnikoff</surname><given-names>S</given-names></name><name><surname>Pascolini</surname><given-names>D</given-names></name><name><surname>Etya&#x02019;ale</surname><given-names>D</given-names></name><name><surname>Kocur</surname><given-names>I</given-names></name><name><surname>Pararajasegaram</surname><given-names>R</given-names></name><name><surname>Pokharel</surname><given-names>G</given-names></name><name><surname>Mariotti</surname><given-names>SP</given-names></name></person-group><article-title>Global data on visual impairment in the year 2002.</article-title><source>Bull World Health Organ</source><year>2004</year><volume>82</volume><fpage>844</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15640920</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>CE</given-names></name><name><surname>Canovas</surname><given-names>R</given-names></name><name><surname>Hagan</surname><given-names>M</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Foster</surname><given-names>A</given-names></name></person-group><article-title>Causes of childhood blindness: results from West Africa, South India and Chile.</article-title><source>Eye</source><year>1993</year><volume>7</volume><fpage>184</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8325414</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanita</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>JR</given-names></name><name><surname>Hejtmancik</surname><given-names>JF</given-names></name><name><surname>N&#x000fc;rnberg</surname><given-names>P</given-names></name><name><surname>Hennies</surname><given-names>HC</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Sperling</surname><given-names>K</given-names></name></person-group><article-title>A novel fan-shaped cataract microcornea syndrome caused by a mutation of CRYAA in an Indian family.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>518</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">16735993</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litt</surname><given-names>M</given-names></name><name><surname>Carrero-Valenzuela</surname><given-names>R</given-names></name><name><surname>LaMorticella</surname><given-names>DM</given-names></name><name><surname>Schultz</surname><given-names>DW</given-names></name><name><surname>Mitchell</surname><given-names>TN</given-names></name><name><surname>Kramer</surname><given-names>P</given-names></name><name><surname>Maumenee</surname><given-names>IH</given-names></name></person-group><article-title>Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human beta-crystallin gene CRYBB2.</article-title><source>Hum Mol Genet</source><year>1997</year><volume>6</volume><fpage>665</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9158139</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name></person-group><article-title>Gamma-S crystallin gene (CRYGS) mutation causes dominant progressive cortical cataract in humans.</article-title><source>J Med Genet</source><year>2005</year><volume>42</volume><fpage>706</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">16141006</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>A</given-names></name><name><surname>Minogue</surname><given-names>PJ</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Reddy</surname><given-names>MA</given-names></name><name><surname>Ainsworth</surname><given-names>JR</given-names></name><name><surname>Bhattacharya</surname><given-names>SS</given-names></name><name><surname>Webster</surname><given-names>AR</given-names></name><name><surname>Hunt</surname><given-names>DM</given-names></name><name><surname>Ebihara</surname><given-names>L</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name><name><surname>Beyer</surname><given-names>EC</given-names></name><name><surname>Berthoud</surname><given-names>VM</given-names></name></person-group><article-title>A novel GJA8 mutation is associated with autosomal dominant lamellar pulverulent cataract: further evidence for gap junction dysfunction in human cataract.</article-title><source>J Med Genet</source><year>2006</year><volume>43</volume><fpage>e2</fpage><pub-id pub-id-type="pmid">16397066</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname><given-names>L</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Chu</surname><given-names>R</given-names></name><name><surname>Ban</surname><given-names>A</given-names></name><name><surname>Eiberg</surname><given-names>H</given-names></name><name><surname>Andres</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>G</given-names></name><name><surname>Qian</surname><given-names>M</given-names></name><name><surname>Cui</surname><given-names>B</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Hayden</surname><given-names>MR</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name></person-group><article-title>Mutant DNA-binding domain of HSF4 is associated with autosomal dominant lamellar and Marner cataract.</article-title><source>Nat Genet</source><year>2002</year><volume>31</volume><fpage>276</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12089525</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graw</surname><given-names>J</given-names></name></person-group><article-title>Genetics of crystallins: Cataract and beyond.</article-title><source>Exp Eye Res</source><year>2009</year><volume>88</volume><fpage>173</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">19007775</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horwitz</surname><given-names>J</given-names></name></person-group><article-title>Alpha-crystallin can function as a molecular chaperone.</article-title><source>Proc Natl Acad Sci USA</source><year>1992</year><volume>89</volume><fpage>10449</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">1438232</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horwitz</surname><given-names>J</given-names></name></person-group><article-title>The function of alpha-crystallin in vision.</article-title><source>Semin Cell Dev Biol</source><year>2000</year><volume>11</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">10736264</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name></person-group><article-title>Small heat shock protein &#x003b1;B-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis.</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>354</volume><fpage>109</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">17222797</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Shinohara</surname><given-names>H</given-names></name><name><surname>Kurobe</surname><given-names>N</given-names></name><name><surname>Inaguma</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Ohshima</surname><given-names>K</given-names></name></person-group><article-title>Tissue distribution and developmental profiles of immunoreactive &#x003b1;B-crystallin in the rat determined with a sensitive immunoassay system.</article-title><source>Biochim Biophys Acta</source><year>1991</year><volume>1074</volume><fpage>201</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2043672</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>C</given-names></name><name><surname>Leonard</surname><given-names>N</given-names></name><name><surname>De Bolle</surname><given-names>X</given-names></name><name><surname>Depiereux</surname><given-names>E</given-names></name></person-group><article-title>ESyPred3D: Prediction of proteins 3D structures.</article-title><source>Bioinformatics</source><year>2002</year><volume>18</volume><fpage>1250</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12217917</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Peitsch</surname><given-names>MC</given-names></name></person-group><article-title>SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.</article-title><source>Electrophoresis</source><year>1997</year><volume>18</volume><fpage>2714</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">9504803</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Ke</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>QK</given-names></name></person-group><article-title>Identi&#x0fb01;cation of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>3461</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16877416</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicart</surname><given-names>P</given-names></name><name><surname>Caron</surname><given-names>A</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Pr&#x000e9;vost</surname><given-names>M</given-names></name><name><surname>Faure</surname><given-names>A</given-names></name><name><surname>Chateau</surname><given-names>D</given-names></name><name><surname>Chapon</surname><given-names>F</given-names></name><name><surname>Tom&#x000e9;</surname><given-names>F</given-names></name><name><surname>Dupret</surname><given-names>J</given-names></name><name><surname>Paulin</surname><given-names>D</given-names></name><name><surname>Fardeau</surname><given-names>M</given-names></name></person-group><article-title>A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy.</article-title><source>Nat Genet</source><year>1998</year><volume>20</volume><fpage>92</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9731540</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>R</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Liang</surname><given-names>JJ</given-names></name><name><surname>Shang</surname><given-names>F</given-names></name></person-group><article-title>A novel alphaB-crystallin mutation associated with autosomal dominant congenital lamellar cataract.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>1069</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">16505043</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>V</given-names></name><name><surname>Francis</surname><given-names>P</given-names></name><name><surname>Reddy</surname><given-names>MA</given-names></name><name><surname>Collyer</surname><given-names>D</given-names></name><name><surname>Vithana</surname><given-names>E</given-names></name><name><surname>MacKay</surname><given-names>I</given-names></name><name><surname>Dawson</surname><given-names>G</given-names></name><name><surname>Carey</surname><given-names>AH</given-names></name><name><surname>Moore</surname><given-names>A</given-names></name><name><surname>Bhattacharya</surname><given-names>SS</given-names></name><name><surname>Quinlan</surname><given-names>RA</given-names></name></person-group><article-title>Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans.</article-title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>1141</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11577372</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selcen</surname><given-names>D</given-names></name><name><surname>Engel</surname><given-names>AG</given-names></name></person-group><article-title>Myo&#x0fb01;brillar myopathy caused by novel dominant negative &#x003b1;B-crystallin mutations.</article-title><source>Ann Neurol</source><year>2003</year><volume>54</volume><fpage>804</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">14681890</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilotto</surname><given-names>A</given-names></name><name><surname>Marziliano</surname><given-names>N</given-names></name><name><surname>Pasotti</surname><given-names>M</given-names></name><name><surname>Grasso</surname><given-names>M</given-names></name><name><surname>Costante</surname><given-names>AM</given-names></name><name><surname>Arbustini</surname><given-names>E</given-names></name></person-group><article-title>&#x003b1;B-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands.</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>346</volume><fpage>1115</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16793013</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inagaki</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Arimura</surname><given-names>T</given-names></name><name><surname>Koga</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Teraoka</surname><given-names>K</given-names></name><name><surname>Chikamori</surname><given-names>T</given-names></name><name><surname>Yamashina</surname><given-names>A</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name></person-group><article-title>&#x003b1;B-crystallin mutation in dilated cardiomyopathy.</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>342</volume><fpage>379</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">16483541</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>RR</given-names></name><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Vijayalakshmi</surname><given-names>P</given-names></name><name><surname>Sergeev</surname><given-names>YV</given-names></name><name><surname>Sundaresan</surname><given-names>P</given-names></name><name><surname>Hejtmancik</surname><given-names>JF</given-names></name></person-group><article-title>Crystallin gene mutations in Indian families with inherited pediatric cataract.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1157</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">18587492</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renkawek</surname><given-names>K</given-names></name><name><surname>Stege</surname><given-names>GJ</given-names></name><name><surname>Bosman</surname><given-names>GJ</given-names></name></person-group><article-title>Dementia, gliosis and expression of the small heat shock proteins hsp27 and alphaB-crystallin in Parkinson&#x02019;s disease.</article-title><source>Neuroreport</source><year>1999</year><volume>10</volume><fpage>2273</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10439447</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volloch</surname><given-names>V</given-names></name><name><surname>Rits</surname><given-names>S</given-names></name></person-group><article-title>A natural extracellular factor that induces Hsp72, inhibits apoptosis, and restores stress resistance in aged human cells.</article-title><source>Exp Cell Res</source><year>1999</year><volume>253</volume><fpage>483</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">10585271</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>JJ</given-names></name><name><surname>Katayama</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>C</given-names></name><name><surname>Harada</surname><given-names>Y</given-names></name><name><surname>Noda</surname><given-names>K</given-names></name><name><surname>Yamamura</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name></person-group><article-title>The relationship between alphaB-crystallin and neuro-fibrillary tangles in Alzheimer&#x02019;s disease.</article-title><source>Neuropathol Appl Neurobiol</source><year>2001</year><volume>27</volume><fpage>180</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11489137</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamradt</surname><given-names>MC</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Sam</surname><given-names>S</given-names></name><name><surname>Cryns</surname><given-names>VL</given-names></name></person-group><article-title>The small heat shock protein &#x003b1;B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation.</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>38731</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12140279</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>JP</given-names></name><name><surname>Garland</surname><given-names>D</given-names></name><name><surname>Duglas-Tabor</surname><given-names>Y</given-names></name><name><surname>Robison</surname><given-names>WG</given-names></name><name><surname>Groome</surname><given-names>A</given-names></name><name><surname>Wawrousek</surname><given-names>EF</given-names></name></person-group><article-title>Targeted disruption of the mouse &#x003b1;A-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein &#x003b1;B-crystallin.</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>884</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9023351</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>JP</given-names></name><name><surname>Garland</surname><given-names>DL</given-names></name><name><surname>Green</surname><given-names>DE</given-names></name><name><surname>Tamm</surname><given-names>ER</given-names></name><name><surname>Giblin</surname><given-names>FJ</given-names></name><name><surname>Wawrouskek</surname><given-names>EF</given-names></name></person-group><article-title>&#x003b1;B -crystallin in lens development and muscle integrity: A gene knockout approach.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><fpage>2924</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">11687538</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augusteyn</surname><given-names>RC</given-names></name><name><surname>Koretz</surname><given-names>JF</given-names></name></person-group><article-title>A possible structure for alpha-crystallin.</article-title><source>FEBS Lett</source><year>1987</year><volume>222</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">3308513</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Su</surname><given-names>T</given-names></name><name><surname>Ke</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>DW</given-names></name><name><surname>Yuan</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zeng</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>QK</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name></person-group><article-title>Cataract mutation P20S of alphaB-crystallin impairs chaperone activity of alphaA-crystallin and induces apoptosis of human lens epithelial cells.</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1782</volume><fpage>303</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18343237</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plater</surname><given-names>ML</given-names></name><name><surname>Goode</surname><given-names>D</given-names></name><name><surname>Crabbe</surname><given-names>MJ</given-names></name></person-group><article-title>Effects of site-directed mutations on the chaperone-like activity of alphaB-crystallin.</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>28558</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">8910485</pub-id></mixed-citation></ref></ref-list></back></article>